-
ESMO OPEN 2024 10.1016/j.esmoop.2024.103961
Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinoma
Hong, MH; Park, S; Vo, T; Cho, J; Jung, HA; Lee, SH; Kim, SH; Zhou, H; Chirovsky, D; Koh, YW; Yoon, SO; Webber, AL; Gumuscu, B; Cho, BC; Ahn, MJ
View PubMed
-
ANN HEMATOL 2024 10.1007/s00277-024-06035-w
Mutational characteristics of extranodal NK/T-cell lymphoma analyzed in relation to clinical prognostic indices
Lee, J; Yoon, SE; Kim, SJ; Kim, WS; Cho, J
View PubMed
-
PATHOL RES PRACT 2024 10.1016/j.prp.2024.155599
Gastric-type extremely well-differentiated adenocarcinoma of the stomach: A rare tumor with diagnostic difficulties and high inter-observer variation in endoscopic pinch biopsies
Ahn, S; Park, S; Koh, HH; Kim, HG; Kim, H; Son, JY; Lee, B; Lee, H; Hwang, S; Cho, J; Lee, YK; Kushima, R; Srivastava, A; Kim, KM
View PubMed
-
CANCER RES TREAT 2024 10.4143/crt.2023.869
Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma
Yoon, SE; Shin, SH; Nam, DK; Cho, J; Kim, WS; Kim, SJ
View PubMed
-
ANN HEMATOL 2024 10.1007/s00277-024-05739-3
Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma
Yoon, SE; Cho, H; Berning, P; Cho, J; Kim, HY; Yoon, DH; Schmit, N; Kim, SJ; Kim, WS
View PubMed
-
ACTA HAEMATOL-BASEL 2024 10.1159/000537962
Primary Nodal Epstein-Barr Virus-Positive T-Cell/NK-Cell Lymphoma: Real-World Experience
Choi, DH; Yoon, SE; Cho, JH; Kim, SJ; Kim, WS
View PubMed
-
DIAGN PATHOL 2024 10.1186/s13000-024-01471-8
Histological criteria for selecting patients who need clonality test for non-gastric MALT lymphoma diagnosis
Park, D; Cho, J
View PubMed
-
CLIN EXP METASTAS 2023 10.1007/s10585-023-10244-4
Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer
Choi, N; Kang, YJ; Cho, J; Oh, D; Jeong, J; Jeong, HS
View PubMed
-
FRONT ONCOL 2023 10.3389/fonc.2023.1194315
The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma
Yoon, SE; Park, S; Cho, J; Ryu, KJ; Yandava, B; Lee, S; Kim, SJ; Kim, WS
View PubMed
-
EUR ARCH OTO-RHINO-L 2023 10.1007/s00405-023-08233-0
Impact of dysplasia at resection margin on oncologic outcome after curative resection of oral tongue squamous cell carcinoma: significance of high-grade dysplastic resection margin
Kim, Y; Lee, C; Heo, Y; Jung, SH; Kang, YJ; Park, SY; Chung, MK; Jeong, HS; Son, YI; Cho, J; Baek, CH; Choi, N
View PubMed
-
EUR ARCH OTO-RHINO-L 2023 10.1007/s00405-023-08128-0
Infiltrative fibrous lesion of the facial nerve mimicking a facial nerve tumor
Seo, HW; Lee, JY; Kim, Y; Cho, J; Cho, YS
View PubMed
-
CANCER RES TREAT 2023 10.4143/crt.2022.1535
Case Report of Erdheim-Chester Disease Successfully Treated with Pegylated Interferon: A Single-Center Experience
Lim, Y; Yoon, SE; Cho, J; Kim, D; Jung, CW
View PubMed
-
CANCER MED-US 2023 10.1002/cam4.6268
A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B-cell lymphoma
Lee, H; Yoon, SE; Kim, SJ; Kim, WS; Cho, JH
View PubMed
-
CANCER MANAG RES 2023 10.2147/CMAR.S407837
Real-World Data Analysis of Survival Outcomes and Central Nervous System Relapses in Testicular Diffuse Large B Cell Lymphoma
Lee, YP; Yoon, SE; Cho, J; Ko, YH; Oh, D; Ahn, YC; Kim, WS; Kim, SJ
View PubMed
-
HUM PATHOL 2023 10.1016/j.humpath.2023.04.007
Clinicopathological and molecular genetic characteristics of primary gastric follicular lymphoma
Kim, H; Shin, D; Son, SM; Cho, JH; Kim, JE; Kim, Y; Jeon, T; Ko, YH
View PubMed
-
ANN HEMATOL 2023 10.1007/s00277-023-05182-w
Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma
Jeon, Y; Yoon, SE; Cho, JH; Kim, SJ; Kim, WS
View PubMed
-
CANCER-AM CANCER SOC 2023 10.1002/cncr.34698
TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients
Cho, J; Kim, E; Yoon, SE; Kim, SJ; Kim, WS
View PubMed
-
FRONT ONCOL 2023 10.3389/fonc.2022.1071281
Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphoma
Jeong, SY; Yoon, SE; Cho, D; Kang, ES; Cho, J; Kim, WS; Kim, SJ
View PubMed
-
VIRCHOWS ARCH 2023 10.1007/s00428-023-03493-x
Comparison of histological and molecular features of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma
Lee, J; Han, JH; Lee, CH; Park, HS; Min, SK; Lee, H; Cho, U; Yoon, SE; Kim, SJ; Kim, WS; Cho, JH
View PubMed
-
CANCER RES TREAT 2023 10.4143/crt.2022.017
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas
Kim, SJ; Kim, YJ; Yoon, SE; Ryu, KJ; Park, B; Park, D; Cho, D; Kim, HY; Cho, J; Ko, YH; Park, WY; Kim, WS
View PubMed
-
BLOOD ADV 2022 10.1182/bloodadvances.2021006305
CD47 overexpression is common in intestinal non-GCB type diffuse large B-cell lymphoma and associated with 18q21 gain
Cho, J; Yoon, SE; Kim, SJ; Ko, YH; Kim, WS
View PubMed
-
CL LYMPH MYELOM LEUK 2022 10.1016/j.clml.2022.07.009
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma
Yoon, SE; Cho, J; Kim, YJ; Kim, SJ; Kim, WS
View PubMed
-
CANCERS 2022 10.3390/cancers14225618
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma
Kim, SJ; Ryu, KJ; Park, B; Yoon, SE; Cho, J; Park, Y; Kim, WS
View PubMed
-
J ONCOL 2022 10.1155/2022/2263217
Survival Outcomes of Patients with Follicular Lymphoma after Relapse or Progression: A Single-Center Real-World Data Analysis
Lee, YP; Lee, MS; Yoon, SE; Cho, JH; Bang, YH; Shim, JH; Kim, WS; Kim, SJ
View PubMed
-
MOL DIAGN THER 2022 10.1007/s40291-022-00605-2
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate
Kim, JM; Kim, B; Kim, E; Jang, M; Cho, JH; Lee, HS; Kwak, Y; Huang, L; Krishnan, R; Bai, SY; Mounawar, M; Kim, KM
View PubMed
-
FRONT MED-LAUSANNE 2022 10.3389/fmed.2022.896494
Metabolic parameters on baseline F-18-FDG PET/CT are potential predictive biomarkers for immunotherapy in patients with head and neck squamous cell carcinoma
Kwon, HR; Cho, JH; Park, S; Lee, SH; Ahn, MJ; Choi, JY; Lee, KH; Jung, HA; Moon, SH
View PubMed
-
HUM PATHOL 2022 10.1016/j.humpath.2022.05.010
Histological features of differentiated dysplasia in the oral mucosa: a review of oral invasive squamous cell carcinoma cases diagnosed with benign or low-grade dysplasia on previous biopsies
Kim, E; Chung, M; Jeong, HS; Baek, CH; Cho, J
View PubMed
-
RADIOGRAPHICS 2022 10.1148/rg.210157
Human Oncoviruses and Thoracic Tumors: Understanding the Imaging Findings
Franquet, T; Franks, TJ; Lee, KS; Marchiori, E; Mazzini, S; Gimenez, A; Johkoh, T; Cho, JH; Galvin, JR
View PubMed
-
ANN HEMATOL 2022 10.1007/s00277-022-04805-y
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma
Lee, YP; Yoon, SE; Cho, J; Ko, YH; Jo, H; Kim, SJ; Kim, WS
View PubMed
-
J CLIN MED 2022 10.3390/jcm11071808
Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma
Choi, SY; Choi, J; Hwang, I; Cho, J; Ko, YH; Jeong, HS
View PubMed
-
CANCER RES TREAT 2022 10.4143/crt.2021.752
Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma
Yoon, SE; Kim, YJ; Shim, JH; Park, D; Cho, J; Ko, YH; Park, WY; Mun, YC; Lee, KE; Cho, D; Kim, WS; Kim, SJ
View PubMed
-
TRANSPLANTATION 2022 10.1097/TP.0000000000003705
Sex Difference in the Tolerance of Hepatic Ischemia-reperfusion Injury and Hepatic Estrogen Receptor Expression According to Age and Macrosteatosis in Healthy Living Liver Donors
Han, S; Cho, J; Wi, W; Lee, KW; Cha, HH; Lee, S; Ahn, JH; Kim, S; Choi, GS; Kim, JM; Ha, SY; Kim, GS; Joh, JW
View PubMed
-
BONE MARROW TRANSPL 2022 10.1038/s41409-022-01605-w
Role of upfront autologous stem cell transplantation in patients newly diagnosed with primary CNS lymphoma treated with R-MVP: real-world data from a retrospective single-center analysis
Yoon, SE; Jo, H; Kang, ES; Cho, D; Cho, J; Kim, WS; Kim, SJ
View PubMed
-
J CANCER 2022 10.7150/jca.69639
Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma
Bang, YH; Shim, JH; Ryu, KJ; Kim, YJ; Choi, ME; Yoon, SE; Cho, J; Park, B; Park, WY; Kim, WS; Kim, SJ
View PubMed
-
ANN DERMATOL 2021 10.5021/ad.2021.33.3.222 2021
Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA
Oh1, SJ; Lee, J; Park, JH; Lee, JH; Cho, J; Ko, YH; Lee, D
View PubMed
-
CANCER MANAG RES 2021 10.2147/CMAR.S309092 2021
Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma
Lee1, YP; Hong, JY; Yoon, SE; Cho, J; Shim, JH; Bang, Y; Kim, WS; Kim, SJ
View PubMed
-
EXP HEMATOL ONCOL 2021 10.1186/s40164-021-00224-3 2021
Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas
Yoon1, SE; Cho, J; Kim, YJ; Ko, YH; Park, WY; Kim, SJ; Kim, WS
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-89754-8 2021
EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma
Lee1, JY; Kim, JH; Bang, H; Cho, J; Ko, YH; Kim, SJ; Kim, WS
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-85332-0 2021
Metabolic activity of extranodal NK/T cell lymphoma on F-18-FDG PET/CT according to immune subtyping
Lim1, CH; Yoon, SE; Kim, SJ; Cho, J; Ko, YH; Lee, KH; Kim, WS
View PubMed
-
FRONT ONCOL 2021 10.3389/fonc.2021.628807 2021
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Lee1, B; Lee, H; Cho, J; Yoon, SE; Kim, SJ; Park, WY; Kim, WS; Ko, YH
View PubMed
-
J CANCER 2021 10.7150/jca.54434 2021
Impact of transformation on the survival of patients diagnosed with follicular lymphoma that progressed within 24 months
Yoon1, SE; Cho, J; Kim, WS; Kim, SJ
View PubMed
-
J SURG ONCOL 2021 10.1002/jso.26386 2021
Tumor dimension-dependent microscopic extensions of hypopharyngeal cancer: Therapeutic implications for larynx-preserving hypopharyngectomy
Shin1, J; Lee, J; Hwang, N; Choi, SY; Park, W; Choi, N; Son, YI; Cho, J; Jeong, HS
View PubMed
-
BMC CANCER 2021 10.1186/s12885-021-07806-8 2021
The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma
Kang1, JH; Lee, SH; Lee, J; Choi, M; Cho, J; Kim, SJ; Kim, WS; Ko, YH; Yoo, HY
View PubMed
-
GUT LIVER 2021 10.5009/gnl19288 2021
Long-term Prognosis of Localized Lymphoid Hyperplasia of the Rectum
Hong1, JT; Kim, ER; Park, SW; Kim, JW; Hong, SN; Chang, DK; Kim, YH; Cho, JH
View PubMed
-
GLAND SURG 2021 10.21037/gs-21-620
Diagnosis and management of malignant sublingual gland tumors: a narrative review
Park, M; Cho, J; Ryu, J; Jeong, HS
View PubMed
-
BLOOD ADV 2021 10.1182/bloodadvances.2021004562
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations
Koh, J; Jang, I; Mun, S; Lee, C; Cha, HJ; Oh, YH; Kim, JM; Han, JH; Paik, JH; Cho, J; Ko, YH; Park, CS; Go, H; Huh, J; Kim, K; Jeon, YK
View PubMed
-
INT J ORAL MAX SURG 2021 10.1016/j.ijom.2021.01.016
Analysis of local invasion and regional spread in malignant sublingual gland tumour: Implications for surgical planning
Park, W; Park, M; Choi, K; Heo, Y; Choi, SY; Cho, J; Ko, YH; Jeong, HS
View PubMed
-
BMC CANCER 2021 10.1186/s12885-021-08695-7
Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing
Cho, J; Yoon, SE; Kim, SJ; Ko, YH; Kim, WS
View PubMed
-
BLOOD 2020 2020
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma an open-label phase 2 study
Kim1, SJ; Lim, JQ; Laurensia, Y; Cho, J; Yoon, SE; Lee, JY; Ryu, KJ; Ko, YH; Koh, Y; Cho, D; Lim, ST; Enemark, MB; D'amore, F; Bjerre, M; Ong, CK; Kim, WS
View PubMed
-
CANCERS 2020 10.3390/cancers12123548 2020
Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma
Ryu1, KJ; Lee, JY; Choi, ME; Yoon, SE; Cho, J; Ko, YH; Shim, JH; Kim, WS; Park, C; Kim, SJ
View PubMed
-
BLOOD 2020 10.1182/blood.2020005026 2020
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma
Kim1, H; Jeong, H; Yamaguchi, M; Sohn, I; Yoon, SE; Byeon, S; Hur, JY; Koh, Y; Yoon, SS; Kim, EJ; Oguchi, M; Miyazaki, K; Taguchi, S; Yoon, DH; Cho, J; Ko, YH; Kim, SJ; Suzuki, R; Kim, WS
View PubMed
-
LEUKEMIA 2020 10.1038/s41375-020-1000-0 2020
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
Lim1, JQ; Huang, DC; Tang, T; Tan, D; Laurensia, Y; Peng, RJ; Wong, EKY; Cheah, DMZ; Chia, BKH; Iqbal, J; Grigoropoulos, NF; Nairismagi, ML; Ng, CCY; Rajasegaran, V; Hong, HM; Kim, SJ; Cho, J; Tse, E; Mow, B; Cai, QC; Poon, L; Cai, QQ; Tan, J; Chan, JY; Lim, JX; Goh, YT; Phipps, C; Rotzschke, O; Cheng, CL; Ha, JCH; Khoo, LP; Loh, YSM; Au-Yeung, R; Chan, TSY; Kwong, YL; Hwang, W; Kim, WS; Bei, JX; Lin, TY; Ong, CK; Lim, ST
View PubMed
-
GENE THER 2020 10.1038/s41434-020-0166-4 2020
Effect of connective tissue growth factor gene editing using adeno-associated virus-mediated CRISPR-Cas9 on rabbit glaucoma filtering surgery outcomes
Lee1, EJ; Han, JC; Park, DY; Cho, J; Kee, C
View PubMed
-
ANN HEMATOL 2020 10.1007/s00277-020-04083-6 2020
A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study
Yoon1, SE; Eun, Y; Huh, K; Chung, CR; Yoo, IY; Cho, J; Cho, D; Ko, YH; Park, S; Kim, WS; Kim, SJ
View PubMed
-
CANCER RES TREAT 2020 10.4143/crt.2019.198 2020
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial
Kim1, SJ; Yoon, DH; Kim, JS; Kang, HJ; Lee, HW; Eom, HS; Hong, JY; Cho, J; Ko, YH; Huh, J; Yang, WI; Park, WS; Lee, SS; Suh, C; Kim, WS
View PubMed
-
MODERN PATHOL 2020 10.1038/s41379-019-0392-8 2020
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression
Cho1, J; Kim, SJ; Park, WY; Kim, J; Woo, J; Kim, G; Yoon, SE; Ko, YH; Kim, WS
View PubMed
-
HEAD NECK-J SCI SPEC 2020 10.1002/hed.26067 2020
Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review
Lee1, T; Cho, J; Baek, CH; Son, YI; Jeong, HS; Chung, MK; Hong, SD; Ahn, YC; Oh, DR; Noh, JM; Park, K; Ahn, MJ; Kim, HJ; Kim, YK; Ko, YH
View PubMed
-
INT J CANCER 2019 10.1002/ijc.32228 2019
Bridging genomics and phenomics of gastric carcinoma
Cho1, J; Ahn, S; Son, DS; Kim, NKD; Lee, KW; Kim, S; Lee, J; Park, SH; Park, JO; Kang, WK; An, JY; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S; Kim, KM
View PubMed
-
MEDICINE 2019 10.1097/MD.0000000000017641 2019
Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997-2016 An observational study
Sim1, J; Takayama, T; Cho, J; Kim, SJ; Kim, WS; Ree, HJ; Ko, YH
View PubMed
-
LEUKEMIA LYMPHOMA 2019 10.1080/10428194.2019.1573998 2019
Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes
Shin1, SH; Kim, YJ; Lee, D; Cho, D; Ko, YH; Cho, J; Park, WY; Park, D; Kim, SJ; Kim, WS
View PubMed
-
J ORAL PATHOL MED 2019 10.1111/jop.12816 2019
Risk of high-grade malignancy in parotid gland tumors as classified by the Milan System for Reporting Salivary Gland Cytopathology
Park1, W; Bae, H; Park, MH; Hwang, NY; Sohn, I; Cho, J; Jeong, HS
View PubMed
-
PATHOL RES PRACT 2019 10.1016/j.prp.2018.11.010 2019
MET is overexpressed in microsatellite instability-high gastric carcinoma
Sim1, J; Heo, YJ; Bae, H; Shin, HC; Kim, B; Cho, J; Kim, ST; Lee, J; Kang, WK; Kim, KM
View PubMed
-
ANN HEMATOL 2019 10.1007/s00277-018-3516-1 2019
Validation of the Marginal Zone Lymphoma International Prognostic Index
Hong1, J; Cho, J; Ko, YH; Kim, SJ; Kim, WS
View PubMed
-
ORAL ONCOL 2019 10.1016/j.oraloncology.2019.01.003 2019
Clinical outcomes and management of facial nerve in patients with parotid gland cancer and pretreatment facial weakness
Park1, W; Park, J; Park, SI; Kim, H; Bae, H; Cho, J; Won, H; Park, M; Jeong, HS
View PubMed
-
PATHOL RES PRACT 2019 10.1016/j.prp.2018.10.024 2019
The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma
Cho1, J; Kim, KM; Kim, HC; Lee, WY; Kang, WK; Park, YS; Ha, SY
View PubMed
-
PATHOLOGY 2019 10.1016/j.pathol.2018.09.057 2019
MMR protein immunohistochemistry and microsatellite instability in gastric cancers
Cho1, J; Kang, SY; Kim, KM
View PubMed
-
ANN SURG ONCOL 2018 10.1245/s10434-018-6731-z 2018
Factors Associated With Host Immune Response and Number of Lymph Nodes: A Large Retrospective Cohort Study
Byeon1, SJ; Heo, YJ; Cho, J; An, JY; Choi, MG; Lee, JH; Bae, JM; Kim, MJ; Sohn, I; Kim, S; Kim, KM; Sohn, TS
View PubMed
-
SCI REP-UK 2018 10.1038/s41598-018-32299-0 2018
Computational measurement of tumor immune microenvironment in gastric adenocarcinomas
Chang1, YH; Heo, YJ; Cho, J; Song, SY; Lee, J; Kim, KM
View PubMed
-
J Diabetes Res 2018 10.1155/2018/5182606 2018
Renal Ischemia-Reperfusion Injury in a Diabetic Monkey Model and Therapeutic Testing of Human Bone Marrow-Derived Mesenchymal Stem Cells
Lee1, KW; Kim, TM; Kim, KS; Lee, S; Cho, J; Park, JB; Kwon, GY; Kim, SJ
View PubMed
-
PATHOL RES PRACT 2018 10.1016/j.prp.2018.02.007 2018
Prognostic significance of epithelial-mesenchymal transition phenotypes in upper urinary tract urothelial carcinoma
Cho1, J; Ha, SY; Kim, SH; Sung, HH; Kwon, GY
View PubMed
